Evidence map›Paper›PMID 41148574›Full record

ArticleNeurology and therapy2025

Patient-Doctor Communication in Migraine: Results from the OVERCOME (Japan) 2nd Study.

Shiho Suzuki, Ryotaro Ishii, Daisuke Danno, Tsubasa Takizawa, Masayuki Hamakawa, Yoshinori Tanizawa, Satoshi Osaga, Nao Sasaki, Chie Hashimoto, Mika Komori

Abstract read
In one paragraph

Article in Neurology and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shiho SuzukiDokkyo Medical University, Mibu, Japan.ORCID http://orcid.org/0009-0007-7430-2078
Ryotaro IshiiKyoto Prefectural University of Medicine, Kyoto, Japan.ORCID http://orcid.org/0000-0002-6976-1081
Daisuke DannoTominaga Hospital, Osaka, Japan.ORCID http://orcid.org/0000-0003-3737-4754
Tsubasa TakizawaKeio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0003-2605-7200
Masayuki HamakawaSocial Survey Research Information Co., Ltd., Tokyo, Japan.ORCID http://orcid.org/0000-0003-1823-8394
Yoshinori TanizawaEli Lilly Japan K.K., Kobe, Japan. tanizawa_yoshinori@lilly.com.ORCID http://orcid.org/0000-0002-5014-2483
Satoshi OsagaEli Lilly Japan K.K., Kobe, Japan.ORCID http://orcid.org/0000-0003-4459-2469
Nao SasakiEli Lilly Japan K.K., Kobe, Japan.ORCID http://orcid.org/0009-0003-2252-6724
Chie HashimotoEli Lilly Japan K.K., Kobe, Japan.ORCID http://orcid.org/0009-0008-0227-8993
Mika KomoriEli Lilly Japan K.K., Kobe, Japan.ORCID http://orcid.org/0000-0003-1887-1296

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDespite the availability of effective treatments, some patients with migraine in Japan do not receive appropriate medical management and treatment for migraine, potentially due to the lack of effective patient-doctor communication. This analysis of the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan)] 2nd study described the current state and challenges of patient-doctor communication in migraine treatment in Japan.

methodsThis analysis included adults with migraine who consulted doctors for headaches/migraine and reported details of their first consultation: their experiences with doctors regarding migraine diagnosis and treatments, migraine-related topics, and treatment goals discussed, and challenges in communication.

resultsAmong the 6762 included respondents, 55.1% (3729/6762) consulted a general practitioner (GP) first for headaches. Of the 3192 respondents diagnosed with migraine and reported the diagnosing doctor's specialty (as GP, specialist, or non-headache specialist), specialists (64.0%; 2044/3192), followed by GPs (31.4%; 1001/3192), mostly commonly diagnosed migraine. In the first consultation, doctors told 48.0% (3249/6762) of respondents they had migraine. In the past year, 3854 respondents discussed migraine-related topics with doctors; most commonly, the use and effectiveness of prescription drugs, and headache symptoms, severity, and frequency [48.9% (1885/3854) to 67.8% (2612/3854)]. Specialists most commonly discussed migraine-related topics with respondents, but non-headache specialists, i.e., obstetricians and gynecologists, most commonly discussed menstrual-related migraine. A total of 1978 respondents had migraine-related topics they wanted to but could not discuss with doctors in the past year. Among them, 32.9% (651/1978) of respondents did not discuss the topics because the doctor did not ask. Although 96.6% (3724/3854) of respondents had treatment goals in mind, 36.0% (1388/3854) never discussed it with doctors.

conclusionOpen and considerate patient-doctor communication and appropriate medical judgment are needed for timely and adequate medical management of migraine. Training doctors in effective communication techniques and considering a migraine diagnosis during consultations may be associated with better patient outcomes.

Indexed as

JapanMigraineOVERCOME studyPatient–doctor communicationTreatment goal

Identifiers

PMID41148574
PMCPMC12623525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.